All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, January 26, 2023
Home » Authors » Ned Stafford

Ned Stafford

Articles

ARTICLES

Germany's Rhön-Klinikum, Swiss firm Medgate to form telemedicine firm

Jan. 14, 2019
By Ned Stafford
No Comments

Israeli data security firm Cynerio raises $7M, will help drive US growth

Jan. 11, 2019
By Ned Stafford
No Comments

Facial analysis study led by FDNA shows AI can detect genetic disorders

Jan. 10, 2019
By Ned Stafford
No Comments

Pq Bypass nabs $60M to develop its Detour system

Jan. 9, 2019
By Ned Stafford
No Comments
HAMBURG, Germany – Startup company Pq Bypass Inc. has completed a round of funding that can provide up to an aggregate of $60 million in equity financing to be used to advance clinical develop of its Detour system, which treats long blockages in leg arteries caused by peripheral arterial disease. The goal of the company is to eventually win U.S. FDA clearance for the system.
Read More

JC Medical reports first successful US treatment of its J-Valve TF system

Jan. 8, 2019
By Ned Stafford
No Comments

Sophia Genetics raises $77M to help fund U.S. expansion, acquire talent

Jan. 7, 2019
By Ned Stafford
No Comments

Curium and Progenics to collaborate in Europe on imaging agent PyL

Jan. 7, 2019
By Ned Stafford
No Comments
HAMBURG, Germany – Paris-based company Curium has signed an exclusive agreement with U.S. firm Progenics Pharmaceuticals Inc. to develop and commercialize in Europe a small-molecule positron emission topography (PET) imaging agent designed by Progenics to visualize prostate cancer.
Read More

Curium and Progenics to collaborate in Europe on imaging agent PyL

Jan. 4, 2019
By Ned Stafford
No Comments

Brainscope gets FDA nod to add indications for TBI device

Jan. 3, 2019
By Ned Stafford
No Comments

Edwards wins FDA approval for Sapien 3 Ultra

Dec. 31, 2018
By Ned Stafford
No Comments
HAMBURG, Germany – Edwards Lifesciences Corp. received U.S. FDA approval to market its Sapien 3 Ultra system for transcatheter aortic valve replacement in severe, symptomatic aortic stenosis patients who are at intermediate or greater risk of open-heart surgery.
Read More
View All Articles by Ned Stafford

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld
    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus pandemic. They are available for free with registration. Note...
  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan. 26, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 26, 2022.
  • Biogen, Eisai win FDA clearance for AD therapy Leqembi

    BioWorld
    As expected, the U.S. FDA gave its go-ahead to lecanemab, an amyloid-beta binder for mild cognitive impairment caused by Alzheimer’s disease (AD) and mild AD –...
  • Stem-cells2.png

    J.P. Morgan Healthcare Conference: ‘Bright’ year ahead for cell, gene therapies, says ARM

    BioWorld
    After long years of painstaking work, the commercialization of cell and gene therapies picked up pace in 2022, with multiple approvals. More progress is expected...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing